Prostaglandins play important roles in inflammation and the maintenance of
normal physiological function of several organ systems. Prostaglandin produ
ction requires the conversion of arachidonic acid to the intermediate prost
aglandin Hz catalysed by the cyclo-oxygenase (COX) enzyme. There are two is
oforms of the COX enzyme, COX-I and COX-2. These isoforms vary in their dis
tribution and expression but are similar in size, substrate specificity and
kinetics. Normal physiological functions are mediated by 'constitutive' CO
X-1, while the inflammatory reponse is mediated by 'inducible' COX-2. Curre
nt nonsteroidal anti-inflammatory drugs inhibit both enzymes to varying deg
rees and can cause adverse effects in the gastrointestinal tract, kidney, r
espiratory system and platelets. Newer, selective COX-2 inhibitors offer re
al hope for safer anti-inflammatory drugs although their long-term safety a
nd efficacy need to be studied as questions remain unanswered about possibl
e physiological functions of COX-2.